ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2023
GOTHENBURG, Sweden, April 5, 2023 /PRNewswire/ -- Zinzino group revenue increased with a total of 18% in Q1 compared with the previous year.
The revenue in March for Zinzino's sales markets increased by 13% and amounted to SEK 135.4 (119.5) million. Faun Pharma's external sales were unchanged and amounted to SEK 9.9 (9.9) million. Overall, the Group increased revenues by 12% to SEK 145.3 (129.4) million compared with the previous year.
The group revenue increased with 18% for Q1 2023 compared with the first quarter last year and amounted to SEK 393.0 (334.4) million.
Revenues were distributed as follows:
Regions, mSEK
23-mar
22-mar
Change
Q1 2023
Q1 2022
Change
The Nordics
26.0
32.8
-21 %
72.8
80.3
-9 %
Central Europe
35.4
22.2
59 %
90.8
59.1
54 %
East Europe
34.6
31.5
10 %
92.6
83.4
11 %
South & West Europe
18.7
14.3
31 %
49.0
38.1
29 %
The Baltics
7.7
6.7
15 %
21.1
18.3
15 %
North America
7.1
5.4
31 %
19.6
14.1
39 %
Asia-Pacific
4.5
6.1
-26 %
15.6
16.4
-5 %
Africa
1.4
0.5
180 %
3.8
1.4
171 %
Zinzino
135.4
119.5
13 %
365.3
311.1
17 %
Faun Pharma
9.9
9.9
0 %
27.7
23.3
19 %
Zinzino Group
145.3
129.4
12 %
393.0
334.4
18 %
Countries in regions:
The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA
Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
Africa: South Africa
For more information: Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
The "Europe
Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)"
report has been added to ResearchAndMarkets.com's
offering.
Welding is one of the critical processes employed in the manufacturing...
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...
Merck , known as MSD outside the United States and Canada, and
NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has
exercised its option to extend the research phase of the companies'
broad, strategic collaboration...
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden.
RIGHT TO PARTICIPATE AND NOTICE
Shareholders who wish to...
The Oslo Business for Peace Award is given to inspiring business
leaders who have put society first.
2019's winners are: Dr Agbor Ashumanyi Ako,
medical director of GiftedMom, Alice Laugher, CEO of
Committed to...
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...